← Back
$VIR All transactions

Vir Biotechnology, Inc.

A 10b5-1 Plan

$ Value

$0

Shares

16,000

Price

$0

Filed

Jun 2

Insider

Name

Napolitano Janet

Title

CIK

0001821008

Roles

Director

Transaction Details

Transaction Date

2025-05-30

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

16,000

Footnotes

Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan. | The RSUs will vest in full on May 30, 2026. | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2024. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.845 to $5.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. | The shares subject to the stock option will vest and become exercisable in full on May 30, 2026.

Filing Info

Accession No.

0001628280-25-028896

Form Type

4

Issuer CIK

0001706431

Napolitano Janet's History

Date Ticker Type Value
2026-03-31 FTNT M $0
2026-03-31 FTNT M $0
2025-12-31 FTNT M $0
2025-12-31 FTNT M $0
2025-09-30 FTNT M $0
2025-09-30 FTNT M $0
2025-08-20 FTNT A $0
2025-06-13 ZM $201K
2025-06-12 FTNT M $0
2025-06-12 FTNT M $0

Other Insiders at VIR (90d)

Insider Bought Sold Last
SATO VICKI L $369K 2026-04-01
De Backer Marianne
President and CEO
$664K 2026-04-06
Sabatini Brent
SVP, Chief Accounting Officer
$70K 2026-03-23